Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane into the cartilage defect on the femoral condyle and/or trochlea of the knee after a traumatic injury.


Clinical Trial Description

Articular cartilage injuries are a prime target for regenerative techniques, since spontaneous healing is poor and untreated defects predispose to osteoarthritis. Common current strategies such as arthroscopic debridement, microfracture, autologous osteochondral grafting, use of allografts and autologous chondrocytes implantation (ACI) still have drawbacks such as long and complex rehabilitation times, technically challenging operation techniques, defect-size limitations, donor-site morbidity, limited graft material and high costs. Furthermore many techniques show unsatisfactory long term results due to inferior quality of repair tissue as compared to native cartilage or have yet to prove the cost versus benefit. These drawbacks could be overcome by using a tissue engineered nasal cartilage graft, thereby reducing donor site morbidity without introducing additional risk of complication or technically challenging techniques.

This study is a phase I, prospective, uncontrolled, investigator initiated clinical trial involving 25 patients, with the objective of demonstrating safety and feasibility in the use of engineered nasal cartilage grafts for repair of articular cartilage. The specific surgical target of the trial is the repair of one or two full-thickness cartilage defects from 2 cm2 to 8 cm2 (per lesion, not exceeding a total of 8 cm2 for all lesions) due to traumatic injury on the femoral condyle and/or trochlea of the knee. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01605201
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase Phase 1
Start date August 29, 2012
Completion date August 15, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT02090140 - Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects N/A
Active, not recruiting NCT02345564 - Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery N/A
Completed NCT02285725 - Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid N/A
Recruiting NCT04000659 - Episealer® Knee System IDE Clinical Study N/A
Terminated NCT02981355 - Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions Phase 4
Completed NCT01554878 - Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV N/A
Completed NCT01576159 - Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises Phase 0
Active, not recruiting NCT01329445 - DeNovo NT Longitudinal Data Collection (LDC) Knee Study N/A